CompletedNot Applicable

Endodontic Medications for Irreversible Pulpitis: Articaine or Eugenol?

France100 participantsStarted 2018-03-22

Plain-language summary

The objective of the study is to determine which of the two commonly used endodontic medications (Eugenol VS Articaine) is most effective in controlling postoperative pain in irreversible pulpitis of the mature permanent tooth in adults. To do so, an assessment of the pain felt by patients will be carried out a few days apart. The supposed results are that the medications are equivalent in terms of effectiveness on the pain, but could then present different economic arguments

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patient, major, affiliated to a social health insurance scheme * Patient having agreed to participate in the study * Urgent consultant patient for irreversible pulpitis * Patient understanding French Exclusion Criteria: * Refusal of the patient to participate in the study * Impossibility of performing the surgical procedure * Impossibility to give the subject information enlightened (difficulty of understanding ...) * Subject under the protection of justice, or under guardianship * General contraindication to endodontic treatment in 2 sessions (high risk of infectious endocarditis, for example) * Chronic intake of analgesic drugs

What they're measuring

Pain evolution (decrease or increase the intensity of the pain)

Timeframe: 7 days

Trial details

NCT IDNCT03472456

SponsorUniversity Hospital, Strasbourg, France

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-03-22

View on ClinicalTrials.gov More Pulpitides trials